Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor
Human Growth Hormone
Neoplasms, Second Primary
Although cancer survivors treated with GH appear to have an increased risk of developing SN compared with survivors not so treated, the elevation of risk due to GH use appears to diminish with increasing length of follow-up. Continued surveillance is essential.